Skip to Content


Kevin Ostrander, CBO at Corium Innovations, Inc.


Chief Business Officer

Kevin has 30+ years of experience in the pharmaceutical industry, having worked in various capacities for BioDelivery Sciences, Glenmark Pharmaceuticals, Sandoz, Mylan, Watson Pharmaceuticals and Elan Drug Delivery.

For the past 20+ years, Kevin has been a leading business development executive, assisting in overall corporate revenue growth through select product/technology partnerships. He has completed 75 transactions with a total value exceeding $1.5 billion.

Kevin holds a BS degree in Biology from SUNY Albany, an MS degree in Pharmaceutical Quality Assurance and Regulatory Affairs from Temple University School of Pharmacy and an MBA in International Business from St. Joseph’s University.